Navigation Links
Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results
Date:5/18/2010

xin. Simcere manufactures and sells antibiotics, anti-cancer medication, stroke management medication and biopharmaceutical drugs such as vaccines. Simcere concentrates its research and development efforts on the treatment of diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, orthopaedics and infectious diseases. For more information about Simcere Pharmaceutical Group, please visit http://www.simcere.com .



    SIMCERE PHARMACEUTICAL GROUP
    PRELIMINARY UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME
    (AMOUNTS EXPRESSED IN THOUSANDS, EXCEPT SHARE AND ADS DATA)

                                              Three months ended March 31,
                                            2009           2010        2010
                                             RMB            RMB         USD

    Product revenue                       436,633        457,648      67,047
    Other revenue                           5,873          1,021         150
    Total revenue                         442,506        458,669      67,197
    Cost of materials and production      (77,320)       (93,096)    (13,639)
    Gross profit                          365,186        365,573      53,558

    Operating expenses:
    Research and development expenses     (25,047)       (30,592)     (4,482)
    Sales, marketing and
     distribution expenses               (219,779)      (236,879)    (34,704)
    General and administrative
     expenses                             (59,288)       (67,240)     (9,851)
    Income from operations                 61,072         30,862       4,521

    Interest income                         2,569          1,296         190
    Interest 
'/>"/>
SOURCE Simcere Pharmaceutical Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Simceres Diosmectite API Passes EU-GMP Inspection
2. Simcere Pharmaceutical Group Successfully Completes Endostar Phase IV Clinical Study
3. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2009 Unaudited Financial Results on Tuesday, March 16, 2010
4. Simcere Receives SFDA Approval to Manufacture and Sell Zanamivir in China
5. Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen
6. Simcere Pharmaceutical Group Announces Jiangsu Yanshens Voluntary Suspension of Production
7. Simcere Pharmaceutical Group to Acquire Additional Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd.
8. Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals
9. Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study
10. Epix Pharmaceuticals, Inc. Announces Additional Information Concerning the May 28, 2010 Auction Sale of EP-3600 MRI Imaging Agent
11. Isis Pharmaceuticals to Discuss Its Cancer Franchise in a Conference Call on Wednesday, May 19
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... RALEIGH, N.C. , Dec. 17, ... (CTMC), and Integrated Clinical Trial Services, LLC (ICTS), ... for clinical trials announce that they have formed ... Services (i-CTMS). i-CTMS will provide a broad range ... biotechnology and medical device companies. i-CTMS ...
(Date:12/15/2014)... 12, 2014 Research and Markets ( ... "Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, ... http://photos.prnewswire.com/prnh/20130307/600769 Global Electrocardiogram Devices ... 2016. The North America accounts ... while Europe claims approximately 27% ...
(Date:12/15/2014)... YORK and HERZLIYA PITUACH, Israel ... "Company") (NASDAQ: IMNP ) announced today that its ... the Board succeeding Dr. Daniel Teper who continues ... a member of Immune,s Board of Directors since 2013. ... "I am delighted to represent the interest of shareholders and ...
Breaking Medicine Technology:Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 2Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 3Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 4Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 2Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 3Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 4
... LAKE, N.J., Jan. 3, 2012  Arena Pharmaceuticals, Inc. (NASDAQ: ... has submitted its response to the Complete Response Letter (CRL) ... review of the lorcaserin New Drug Application (NDA). Lorcaserin is ... weight loss, in patients who are obese (Body Mass Index, ...
... Jan. 3, 2012 IDEXX Laboratories, Inc. (NASDAQ: ... 30 th Annual J.P. Morgan Healthcare Conference. Jonathan W. ... on the Company on Monday, January 9, 2012 at 2:30 ... California. Individuals can access the live audio webcast of the ...
Cached Medicine Technology:Arena Submits Response to FDA Complete Response Letter for Lorcaserin 2Arena Submits Response to FDA Complete Response Letter for Lorcaserin 3Arena Submits Response to FDA Complete Response Letter for Lorcaserin 4Arena Submits Response to FDA Complete Response Letter for Lorcaserin 5Arena Submits Response to FDA Complete Response Letter for Lorcaserin 6
(Date:12/19/2014)... Albuquerque, New Mexico (PRWEB) December 19, 2014 ... pain relief industry is excited to announce a new ... gauss rare earth magnets. These are the strongest neodymium ... therapy necklace. Pain Free Living developed the Superior Magnetics ... magnets. , “Pain Free Living performs magnetic therapy using ...
(Date:12/19/2014)... From November 24, 2014, Siddhi Yoga ... 2014 in its Goa retreat . This is the ... winters, from November to March, Siddhi Yoga will organize four ... Goa. The Goa training sessions will conclude in March 2015. ... training, the 10th intake is also a 200 YTT ...
(Date:12/19/2014)... After a 13-year absence from active touring, the ... stage to entertain his many worldwide fans. Trisha Yearwood ... successful tour has been steadily expanding since the very ... Ticketability.com for a large inventory of Garth Brooks ... , Music fans have had a long wait for ...
(Date:12/19/2014)... Consilium Staffing, Your Partner in Locum ... Federal Health Professionals annual meeting in Washington, D.C., ... and federal healthcare providers. , In addition, ... Engagement (NVSBE) conference last week in Atlanta, Georgia. ... solution in addressing our nation’s shortage of physicians,” ...
(Date:12/19/2014)... good shape seems to reduce your risk of high blood ... than 57,000 Americans, including more than 35,000 with high blood ... Those in the poorest shape had a more than 70 ... of the study, compared to a 50 percent chance for ... than 8,000 people diagnosed with high blood pressure during the ...
Breaking Medicine News(10 mins):Health News:New Superior Magnetic Necklace Relieves Migraine Headache 2Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 2Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 3Health News:Garth Brooks Tickets for Joe Louis Arena: Ticketability.com Becomes a Popular Destination for Discount Tickets for Garth Brooks’ Detroit Concerts Set for February 27-28 2Health News:Consilium Staffing Increasing Awareness of Locum Tenens through Conference Appearances 2Health News:Being Fit Keeps Blood Pressure in Check 2
... For many years, consumers have,been able to take out ... cosmetic surgeries, but they haven,t been able to borrow,money ... could save their,lives., As a result, many drug ... they need., The federal government is aware of ...
... May 14 An estimated 130,000 North,Carolinians suffer ... Easley and his wife Mary are joining the ... of,fibromyalgia during National Women,s Health Week. "It is ... diagnosis and treatment of,fibromyalgia as it often takes ...
... Duska Therapeutics,Inc. (OTC Bulletin Board: DSKA.OB) ... from the University of Pennsylvania,s Center for,Research ... the results of,the Company,s sponsored study showing ... and increases fertilizing,capability in mice., The ...
... Marcy Kaptur (D-Ohio) received the annual Joseph F. Boyle ... of Physicians (ACP) last night. The award is given ... an official capacity who has provided outstanding public service ... presenting the award to Rep. Kaptur, David L. Bronson, ...
... The latest information on the biology and treatment of testicular ... presented at the Symposium on Testicular Cancer organized by the ... 15-16 May in Munich, Germany. , "Testicular cancer is the ... and thirty-five and has seen the strongest increase in incidence ...
... /Xinhua-PRNewswire-FirstCall/ -- China Nepstar,Chain Drugstore Ltd. (NYSE: ... drugstore chain in China based on the number ... with the Shenzhen Charity,Federation to organize a program ... earthquake in Sichuan province, China. Specifically, the program ...
Cached Medicine News:Health News:A Better Tomorrow Becomes One of the First Rehabilitation Clinics in the Nation to Offer Financing for Its Drug, Alcohol and Gambling Treatment Programs 2Health News:Triangle Group Raises Awareness of Fibromyalgia 2Health News:Duska Therapeutics Sponsored University of Pennsylvania Study Demonstrates ATP Improves Sperm Motility and In Vitro Fertilization in Animals 2Health News:Duska Therapeutics Sponsored University of Pennsylvania Study Demonstrates ATP Improves Sperm Motility and In Vitro Fertilization in Animals 3Health News:Duska Therapeutics Sponsored University of Pennsylvania Study Demonstrates ATP Improves Sperm Motility and In Vitro Fertilization in Animals 4Health News:Ohio congresswoman cited by American College of Physicians 2Health News:Symposium focuses on curable cancer that affects young men 2Health News:China Nepstar Chain Drugstore Organizing An Earthquake Relief Program 2Health News:China Nepstar Chain Drugstore Organizing An Earthquake Relief Program 3
Porous foundation 470 series....
The Opteon stem meets the challenge of providing a high-quality, cost-effective hip implant for the moderate demand patient....
Exactech's AcuMatch C-Series (cemented femoral stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
The link ribbed hip stem for cementless primary hip replacement surgery....
Medicine Products: